Noventra Pharma Growth Matrix (12mg Prefilled Pen - CJC-1295, Ipamorelin & Tesamorelin)

Growth Matrix 12mg is a multi-peptide research formulation combining CJC-1295, Ipamorelin, and Tesamorelin, supplied in a pre-reconstituted pen format for controlled dispensing. This blend is investigated for its role in growth hormone-related signalling and endocrine pathway regulation.

CJC-1295 and Tesamorelin are growth hormone-releasing hormone (GHRH) analogues studied for their interaction with pituitary signalling pathways, while Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist investigated for its role in stimulating endogenous growth hormone release via complementary mechanisms.

Key Features:

• 12mg total peptide blend: CJC-1295, Ipamorelin, and Tesamorelin

• Prefilled pen format for controlled and consistent application

• Investigated for roles in growth hormone and endocrine signalling pathways

• Studied in relation to GH and IGF-1 regulatory processes

• Associated in research with sleep-related hormone cycles and metabolic pathways

• Commonly included in metabolic and performance-focused research settings

Suggested Use:
For research purposes only. Protocols vary depending on study design and should be determined by qualified professionals in an appropriate setting.

Storage:

• Store at 2–8°C at all times (refrigerated)

• Do not freeze

• Protect from light

• Avoid prolonged exposure to room temperature

• Use within a limited timeframe once in use (based on formulation stability)

Important Information:
This product is an investigational compound and is not approved for human or veterinary use. Intended strictly for laboratory research purposes. Not for use by individuals under 18, pregnant or breastfeeding individuals, or for any therapeutic application. Ensure compliance with applicable regulations.